https://ir.scynexis.com/news/rss en-us https://d1io3yog0oux5.cloudfront.net/scynexis/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.scynexis.com/news/detail/377/scynexis-reports-third-quarter-2026-financial-results-and-provides-corporate-update Thu, 05 Nov 26 08:20:00 -0500 https://ir.scynexis.com/news/detail/377/scynexis-reports-third-quarter-2026-financial-results-and-provides-corporate-update https://ir.scynexis.com/news/detail/376/scynexis-to-participate-in-the-3rd-annual-guggenheim-healthcare-innovation-conference Thu, 29 Oct 26 08:00:00 -0400 https://ir.scynexis.com/news/detail/376/scynexis-to-participate-in-the-3rd-annual-guggenheim-healthcare-innovation-conference https://ir.scynexis.com/news/detail/375/scynexis-completes-phase-1-study-of-intravenous-scy-247-a-novel-triterpenoid-antifungal-in-development-for-treatment-and-prevention-of-invasive-fungal-diseases Thu, 22 Oct 26 08:00:00 -0400 https://ir.scynexis.com/news/detail/375/scynexis-completes-phase-1-study-of-intravenous-scy-247-a-novel-triterpenoid-antifungal-in-development-for-treatment-and-prevention-of-invasive-fungal-diseases https://ir.scynexis.com/news/detail/374/scynexis-to-feature-scy-247-in-a-pipeline-presentation-at-idweek Wed, 21 Oct 26 16:05:00 -0400 https://ir.scynexis.com/news/detail/374/scynexis-to-feature-scy-247-in-a-pipeline-presentation-at-idweek https://ir.scynexis.com/news/detail/373/scynexis-announces-phase-1-study-results-for-scy-770-a-novel-highly-selective-oral-direct-ampk-activator-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd Tue, 06 Oct 26 07:30:00 -0400 https://ir.scynexis.com/news/detail/373/scynexis-announces-phase-1-study-results-for-scy-770-a-novel-highly-selective-oral-direct-ampk-activator-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd https://ir.scynexis.com/news/detail/372/scynexis-awarded-barda-contract-providing-up-to-214-million-in-non-dilutive-funding-for-the-development-of-scy-247 Mon, 28 Sep 26 07:30:00 -0400 https://ir.scynexis.com/news/detail/372/scynexis-awarded-barda-contract-providing-up-to-214-million-in-non-dilutive-funding-for-the-development-of-scy-247 https://ir.scynexis.com/news/detail/371/scynexis-appoints-seasoned-industry-veteran-steven-k-burke-m-d-to-its-board-of-directors Tue, 22 Sep 26 08:00:00 -0400 https://ir.scynexis.com/news/detail/371/scynexis-appoints-seasoned-industry-veteran-steven-k-burke-m-d-to-its-board-of-directors https://ir.scynexis.com/news/detail/370/scynexis-appoints-todd-minga-m-d-as-senior-vice-president-research-development Tue, 15 Sep 26 08:00:00 -0400 https://ir.scynexis.com/news/detail/370/scynexis-appoints-todd-minga-m-d-as-senior-vice-president-research-development https://ir.scynexis.com/news/detail/369/scynexis-announces-appointment-of-sanjay-subramanian-as-chief-financial-officer Thu, 10 Sep 26 08:00:00 -0400 https://ir.scynexis.com/news/detail/369/scynexis-announces-appointment-of-sanjay-subramanian-as-chief-financial-officer https://ir.scynexis.com/news/detail/368/scynexis-to-participate-in-upcoming-investor-conferences Tue, 01 Sep 26 08:30:00 -0400 https://ir.scynexis.com/news/detail/368/scynexis-to-participate-in-upcoming-investor-conferences